← Back to headlines

FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer

This story is reported by Cure Today. Read what other outlets are saying below, then open the original report for full details.

FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer · NabkaNews